Philip A. Jones

Internal Medicine
3001 W Dr Martin Luther King Jr Blvd
Tampa, FL 33607

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications

Fesoterodine treatment of pediatric patients with neurogenic detrusor overactivity: A 24-week, randomized, open-label, phase 3 study.

Fesoterodine treatment of pediatric patients with neurogenic detrusor overactivity: A 24-week, randomized, open-label, phase 3 study.

Journal: Journal of pediatric urology
Published: July 28, 2022

Toxicity of nanomaterials due to photochemical degradation and the release of heavy metal ions.

Toxicity of nanomaterials due to photochemical degradation and the release of heavy metal ions.

Journal: Nanoscale
Published: September 08, 2020

Impairments of cells and genomic DNA by environmentally transformed engineered nanomaterials.

Impairments of cells and genomic DNA by environmentally transformed engineered nanomaterials.

Journal: Nanoscale
Published: July 23, 2013
Showing 1-3 of 3

Last Updated: 09/26/2026